Dernières publications scientifiques

  • Temporal trends and clinical determinants of urinary diversion after radical cystectomy.

  • Auteurs Pellegrino F, de Angelis M, Scilipoti P, Longoni M, Subiela JD, Contieri R, Afferi L, Zamboni S, Suardi N, Musi G, Luzzago S, D'Andrea D, Laukhtina E, Soria F, Gontero P, Del Giudice F, Fallara G, Roupret M, Grobet-Jeandin E, Baudewyns A, Tanaka H, Matsumoto S, Fujii Y, Proietti F, Simone G, Schulz GB, Pyrgidis N, Ploussard G, Antonelli A, Bertolo R, Roumiguie M, Bajeot AS, Resca S, Beatrici E, Lambert E, Mottrie A, Mir MC, Umari P, Teoh J, Wong C, Mertens LS, Pichler R, Mori K, Ślusarczyk A, Poyet C, Albisinni S, Aziz A, Volpe A, Shariat S, Pradere B, Karakiewicz P, Necchi A, Ferro M, Montorsi F, Briganti A, Moschini M
  • Auteurs (entité) BAUDEWYNS ARTHUR
  • Revue BJU Int
  • Date de publication 2025-10
Temporal trends and clinical determinants of urinary diversion after radical cystectomy.
  • RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer.

  • Auteurs Jacobs F, D'Amico S, Ferraro E, Agostinetto E, Tondini C, Gaudio M, Benvenuti C, Gerosa R, Saltalamacchia G, Zazzetti E, Di Rienzo R, Buonaiuto R, Martorana F, Chirco A, De Sanctis R, Della Porta MG, Santoro A, Vigneri P, Arpino MG, Giuliano M, Fornier M, de Azambuja E, Zambelli A
  • Auteurs (entité) AGOSTINETTO ELISA
  • Revue ESMO Open
  • Date de publication 2025-10
RSC4All as a machine learning nomogram to predict RSClin™ results in HR+/HER2- node-negative early breast cancer.
  • The Renin-Angiotensin-Aldosterone System in Cardiac Surgery and Angiotensin II Therapy for Vasoplegia.

  • Auteurs Zarbock A, Vincent JL, De Backer D, Bellomo R, Legrand M, Khanna AK, Ostermann M, Kotfis K, Filippo A, Wieruszewski PM, Leone M, Girardis M, Ferrer R, Kotani Y, Pickkers P, De Pascale G, Tissieres P, Landoni G
  • Auteurs (entité) Vincent Jean Louis
  • Revue Anesth Analg
  • Date de publication 2025-10
The Renin-Angiotensin-Aldosterone System in Cardiac Surgery and Angiotensin II Therapy for Vasoplegia.
  • Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.

  • Auteurs Bergiers I, Köse MC, Skerget S, Malfait M, Fourneau N, Ellis JC, Vanhoof G, Smets T, Verbist B, De Maeyer D, Van Houdt J, Van der Borght K, Verona R, Heidrich B, Kurth W, Delforge M, Meuleman N, Van Droogenbroeck J, Vlummens P, Heuck CJ, Beguin Y, Bahlis N, Casneuf T, Caers J
  • Auteurs (entité) MEULEMAN NATHALIE
  • Revue PLoS Genet
  • Date de publication 2025-10
Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma.
Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasme

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Voir toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola